Cable Hill Partners, LLC Gritstone Bio, Inc. Transaction History

Cable Hill Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$9.2 - $15.7 $9,200 - $15,700	-1,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$9.97 - $18.96 $4,985 - $9,480	500 Added 100.0%	1,000 $13,000
Q4 2018 Feb 12, 2019	SELL	$11.61 - $31.1 $3,483 - $9,330	-300 Reduced 37.5%	500 $8,000
Q3 2018 Nov 14, 2018	BUY	$14.24 - $14.24 $11,392 - $11,392	800 New	800 $10,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.